Literature DB >> 24072444

From monitoring to vigilance about patient adherence to new oral anticoagulants.

Bernard Vrijens1, John Urquhart.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24072444     DOI: 10.1093/europace/eut243

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


× No keyword cloud information.
  5 in total

1.  Anti-FXa-IIa activity test in Asian and its potential role for drug adherence evaluation in patients with direct oral anticoagulants: a nationwide multi-center synchronization study.

Authors:  Zhiyan Liu; Qiufen Xie; Qian Xiang; Hanxu Zhang; Guangyan Mu; Zinan Zhao; Taotao Hu; Tingting Wu; Na Wang; Jinhua Zhang; Yan Qian; Shuang Zhou; Zining Wang; Jie Jiang; Yatong Zhang; Hongtao Song; Yimin Cui
Journal:  Cardiovasc Diagn Ther       Date:  2020-10

2.  Adherence to Rivaroxaban, Dabigatran, and Apixaban for Stroke Prevention in Incident, Treatment-Naïve Nonvalvular Atrial Fibrillation.

Authors:  Joshua D Brown; Anand R Shewale; Jeffery C Talbert
Journal:  J Manag Care Spec Pharm       Date:  2016-11

3.  Real-world adherence for direct oral anticoagulants in a newly diagnosed atrial fibrillation cohort: does the dosing interval matter?

Authors:  Phuong N Pham; Joshua D Brown
Journal:  BMC Cardiovasc Disord       Date:  2019-03-19       Impact factor: 2.298

4.  Adherence to Rivaroxaban, Dabigatran, and Apixaban for Stroke Prevention for Newly Diagnosed and Treatment-Naive Atrial Fibrillation Patients: An Update Using 2013-2014 Data.

Authors:  Joshua D Brown; Anand R Shewale; Jeffery C Talbert
Journal:  J Manag Care Spec Pharm       Date:  2017-09

5.  Trends in antithrombotic drug use and adherence to non-vitamin K oral anticoagulants in the Netherlands.

Authors:  Susan Hanemaaijer; Fong Sodihardjo; Annemieke Horikx; Michel Wensing; Peter A G M De Smet; Marcel L Bouvy; Martina Teichert
Journal:  Int J Clin Pharm       Date:  2015-08-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.